home
about
news
browse
search
forum
media comparison
rating information
people
links
feedback
contact info
Register your email address to receive our free newsletter:
In advanced pancreatic cancer patients, a novel anti-neovascular therapy added to standard... read more
It seems like every few weeks there's some new food, drink, berry or vegetable being touted as the... read more
New data on a bivalent human papilloma virus (HPV) vaccine show it provides protection out to more... read more
OWA CITY, IOWA | Stroke patients who undergo early treatment with antidepressants experience... read more
TORONTO | Results from A Diabetes Outcome Progression Trial (ADOPT) were met with both excitement... read more
Health Canada has approved Sutent (sunitinib) capsules to treat GIST for patients who have failed... read more
BERGEN, NORWAY | A unique and much-needed phase III study comparing the outcomes of psychological... read more
DENVER | Exercise can reverse the negative effects of physical inactivity on cardiovascular risk,... read more
NEW YORK | The first drug in a new class of agents for the treatment of high blood pressure-the... read more
Delayed tumour progression helps glioblastoma multiforme patients live longer SAN FRANCISCO | A... read more
EDMONTON | Because statins reduce heart disease risk in those with diabetes and chronic kidney... read more
Despite encouraging phase III study results showing the cancer drug bortezomib offers relapsed... read more
SAN DIEGO | Diabetic men with low testosterone levels could possibly find another advantage in... read more
Researchers took a closer look at the massive data from a major clinical trial and found that... read more
TORONTO | The angiotensin receptor blocker eprosartan (Teveten) won out in a head-to-head... read more